MELPHALAN FLUFENAMIDE DISCONTINUED (has an active metabolite) | MELPHALAN FLUFENAMIDE | ATC L01AA03 ATC L01AA10
ANTINEOPLASTIC A PEPTIDE CONJUGATED ALKYLATING DRUG TREATMENT OF REFRACTORY MULTIPLE MYELOMA NITROGEN MUSTARD DRUG PRODRUG | INTRAVENOUS | Tmax 0.5 HOUR VD 35 LITER Cl 692 LITER / HOUR HT 0.035 HOUR SOLUBILITY SPARSELY SOLUBLE IN AQUEOUS SOLUTIONS | DNA | Unknown more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |